As the National Animal Supplement Council celebrated its 25th anniversary, industry leaders focused on initiatives that could shape the future of animal health supplements.

From “clinically proven” challenges to Proposition 65 actions and pricing lawsuits, AHPA’s latest workshop explored how dietary supplement brands can strengthen claims substantiation, reduce liability, and stay ahead of mounting regulatory and litigation pressures.

Blaming DSHEA for “gas station drugs” misses the real issue: enforcement gaps, not lack of laws, according to a dietary supplement industry perspective.

With anticipated growth over 15%, the human microbiome market represents a huge commercial opportunity for suppliers, brands and service providers to address current and emerging consumer needs.

While gut health remains the top driver in the U.S., other motivations are emerging in the microbiome space. Explore the opportunities with prebiotics.

A new prebiotics monograph in Canada sets clearer rules for ingredients, claims, and labeling—marking a major shift for the NHP and supplement industry.

Smart self-care, science-backed supplements, and testing: Organic & Natural Health outlines a prevention playbook for 2026.

Integrative health is no longer on the fringes; it’s actively redefining prevention, performance, and patient care.

Described as “much-needed reform around claims language, drug preclusion, and federal supremacy clause reform to forestall state-by-state regulation over supplements,” take a look at “DSHEA 10.0.”